Vaginal Cuff Brachytherapy Fractionation Study

The purpose of this study is to see the effects of two different standard of care treatments of endometrial cancer on sexual dysfunction. This study will compare two standard of care treatments: HDR (high dose radiation) vaginal brachytherapy 3 fractions of 7 Gy to HDR vaginal brachytherapy 6 fractions of 4Gy for early stage endometrial cancer.

Trial Details

NCT ID
NCT03785288
Phase
PHASE3
Sponsor
Kara Romano, MD
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • HDR vaginal brachytherapy
Locations (sample)
  • Baltimore, Maryland, United States|39.29038,-76.61219
  • Syracuse, New York, United States|43.04812,-76.14742
  • Charlottesville, Virginia, United States|38.02931,-78.47668

Key Eligibility Criteria

  • Willingness and ability to provide written informed consent and to comply with the study protocol as judged by the investigator.
  • Surgery consisted of Total Abdominal or Laparoscopic Hysterectomy and Bilateral Salpingo Oophorectomy (TH-BSO) with or without lymph node dissection.
  • Subject must have FIGO Stage I-II (grade 1-3) pathologically proven (histologic) endometrioid cancer, including all subtypes. Serous, clear cell, a…
  • Subjects must have no measurable disease after surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →